The authors further demonstrated that SIRT3 loss reduced IDH2 activities by decreasing IDH2 dimerization and that IDH2 acetylation at lysine 413 impairs mitochondrial respiration and detoxification, increases ROS production, and correlates with Luminal B breast cancer risk [67]. Here, IDH2 is linked to breast carcinoma.